Paper33575950
Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial.
Jing S and 7 others. Adv Ther, 2021. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics and Pharmacodynamics of Esomeprazole/Sodium Bicarbonate Immediate-Release Capsules in Healthy Chinese Volunteers: A Cross-Over, Randomized Controlled Trial. Papers, record 33575950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33575950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Esomeprazole | Major topic |
| Proton Pump Inhibitors | Major topic |
| Sodium Bicarbonate | Major topic |
| Bicarbonates | |
| Capsules | |
| China | |
| Cross-Over Studies | |
| Healthy Volunteers | |
| Humans |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28780072 | Presentation and Epidemiology of Gastroesophageal Reflux Disease. | Gastroenterology | 2018 | https://conductscience.org/library/papers/28780072 | PubMed |
| 2 | 28242110 | Peptic ulcer disease. | Lancet | 2017 | https://conductscience.org/library/papers/28242110 | PubMed |
| 3 | 27840364 | 25 Years of Proton Pump Inhibitors: A Comprehensive Review. | Gut Liver | 2017 | https://conductscience.org/library/papers/27840364 | PubMed |
| 4 | 27206157 | Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. | Curr Opin Gastroenterol | 2016 | https://conductscience.org/library/papers/27206157 | PubMed |
| 5 | 26629969 | An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease. | JAMA Surg | 2016 | https://conductscience.org/library/papers/26629969 | PubMed |
| 6 | 26661629 | Esomeprazole induced galactorrhea: a novel side effect. | Clin J Gastroenterol | 2016 | https://conductscience.org/library/papers/26661629 | PubMed |
| 7 | 26970404 | Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. | J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26970404 | PubMed |
| 8 | 28930292 | Proton-pump inhibitors: understanding the complications and risks. | Nat Rev Gastroenterol Hepatol | 2017 | https://conductscience.org/library/papers/28930292 | PubMed |
| 9 | 29620484 | Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. | Expert Opin Drug Metab Toxicol | 2018 | https://conductscience.org/library/papers/29620484 | PubMed |
| 10 | 25473155 | CYP2C19 polymorphism influences Helicobacter pylori eradication. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25473155 | PubMed |
| 11 | 25974703 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. | Clin Pharmacol Ther | 2015 | https://conductscience.org/library/papers/25974703 | PubMed |
| 12 | 29311135 | Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy Subjects. | Drug Metab Dispos | 2018 | https://conductscience.org/library/papers/29311135 | PubMed |
| 13 | 31006731 | Association of CYP2C19 Polymorphisms With Clopidogrel Reactivity and Clinical Outcomes in Chronic Ischemic Stroke. | Circ J | 2019 | https://conductscience.org/library/papers/31006731 | PubMed |
| 14 | 24440142 | Impact of CYP2C19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation. | Thromb Res | 2014 | https://conductscience.org/library/papers/24440142 | PubMed |
| 15 | 18958459 | Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs). | Eur J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/18958459 | PubMed |
| 16 | 25469781 | Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid. | Basic Clin Pharmacol Toxicol | 2015 | https://conductscience.org/library/papers/25469781 | PubMed |
| 17 | 16259581 | Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. | Expert Opin Pharmacother | 2005 | https://conductscience.org/library/papers/16259581 | PubMed |
| 18 | 25706883 | Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec. | PLoS One | 2015 | https://conductscience.org/library/papers/25706883 | PubMed |
| 19 | 23821352 | International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences. | AAPS J | 2013 | https://conductscience.org/library/papers/23821352 | PubMed |
| 20 | 24218038 | Futility rules in bioequivalence trials with sequential designs. | AAPS J | 2014 | https://conductscience.org/library/papers/24218038 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36814893 | Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/36814893 | PubMed |
| 36670124 | Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers. | Sci Rep | 2023 | https://conductscience.org/library/papers/36670124 | PubMed |
| 34992346 | Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34992346 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| ChiCTR | ChiCTR1900024935 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33575950
GET https://conductscience.org/api/papers/v1/33575950/references?page=2